PATH
The numbers were fine. The vibe was not.
UiPath came in with a solid-enough second quarter: earnings of 15 cents per share matched Wall Street, while revenue of $410.26 million beat estimates. The company also nudged up its fiscal 2027 revenue outlook to $1.789 billion-$1.794 billion, a small but meaningful signal that management sees better footing ahead.
But the market wanted a bigger plot twist
Even with the raise, the stock fell hard — down 17.07% to $15.11 at the time of publication. Translation: the market wasn’t in the mood for a polite beat-and-raise. It wanted proof that UiPath’s AI engine is more than a flashy side quest.
Analysts mostly stayed constructive, but the tone was basically, “show me.”
- Canaccord downgraded the stock to Hold, even while lifting its price target to $17
- DA Davidson kept a Neutral and bumped its target to $16
- RBC stayed Sector Perform and raised its target to $17
- TD Cowen held at Hold and moved its target to $16
The real debate: AI hype vs. actual acceleration
The good news is that analysts pointed to healthier pipeline trends, better customer retention, and rising AI adoption. The less-good news is that many think the stock’s recent rally already priced in a lot of that optimism.
That means UiPath is now in the classic “great story, prove it faster” phase. The upcoming investor day could matter a lot, because that’s where management gets a shot at convincing the market that the AI monetization part of the script is more than a teaser trailer.
Big picture
UiPath is still making progress, but this quarter showed that investors are grading on a harsher curve. If growth doesn’t clearly reaccelerate soon, the stock may keep getting treated like it’s ahead of its own fundamentals.